Narrative review of diagnosis, management and treatment of dysphagia and sialorrhea in amyotrophic lateral sclerosis.

J Neurol

Department of Neurology, Hannover Medical School, 1, Carl-Neuberg-Strasse, 30625, Hannover, Germany.

Published: October 2024

The degenerative motor neuron disorder amyotrophic lateral sclerosis (ALS) frequently leads bulbar symptoms like dysarthria, dysphagia, and sialorrhea, in approximately one-third of cases being the initial symptom. Throughout the disease, more than two-thirds of ALS patients experience dysphagia, regardless of the region of onset. In this review, we aimed to offer an updated overview of dysphagia and sialorrhea in ALS, covering its diagnosis, monitoring, and treatment in clinical practice. Regular assessment of dysphagia and sialorrhea during each patient visit is essential and should be a standard aspect of ALS care. Early discussion of potential treatments such as high-calorie diets or percutaneous endoscopic gastrostomy (PEG) is crucial. Furthermore, this review highlights and discusses potential areas for improvement in both clinical practice and research.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11447084PMC
http://dx.doi.org/10.1007/s00415-024-12657-xDOI Listing

Publication Analysis

Top Keywords

dysphagia sialorrhea
16
amyotrophic lateral
8
lateral sclerosis
8
clinical practice
8
dysphagia
5
narrative review
4
review diagnosis
4
diagnosis management
4
management treatment
4
treatment dysphagia
4

Similar Publications

Management of paediatric sialorrhea.

Curr Opin Otolaryngol Head Neck Surg

December 2024

Department of Neurodevelopment and Disability, The Royal Children's Hospital, Parkville Department of Pediatrics, The University of Melbourne, Murdoch Children's Research Institute, Melbourne, Australia.

Purpose Of Review: To summarize current understanding of and recent literature on the management of sialorrhea in children.

Recent Findings: Sialorrhea is a symptom of oropharyngeal dysphagia and reduced clearance. Sialorrhea can be anterior, with forward overflow of saliva, causing skin rash, social embarrassment and spillage on communication devices; or posterior, where there is pharyngeal pooling of saliva, which may cause aspiration.

View Article and Find Full Text PDF

Feeding and Nutritional Key Features of Crisponi/Cold-Induced Sweating Syndrome.

Genes (Basel)

August 2024

Centre for Rare Diseases and Transition, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

Article Synopsis
  • - Feeding difficulties are a common issue for patients with Crisponi/cold-induced sweating syndrome type 1 (CS/CISS1), observed from birth to adulthood in a study of 14 patients in Rome.
  • - All participants required enteral feeding at birth, with solid food introduction delayed for 43% until after 18 months, and mealtime challenges included fatigue while chewing, food spillage, and drooling.
  • - The findings enhance the understanding of CS/CISS1, aiding in better management and prevention of complications in patients with this ultra-rare disease.
View Article and Find Full Text PDF

The degenerative motor neuron disorder amyotrophic lateral sclerosis (ALS) frequently leads bulbar symptoms like dysarthria, dysphagia, and sialorrhea, in approximately one-third of cases being the initial symptom. Throughout the disease, more than two-thirds of ALS patients experience dysphagia, regardless of the region of onset. In this review, we aimed to offer an updated overview of dysphagia and sialorrhea in ALS, covering its diagnosis, monitoring, and treatment in clinical practice.

View Article and Find Full Text PDF

RimabotulinumtoxinB: An Update.

Dermatol Surg

September 2024

Marmur Medical, New York, New York.

Article Synopsis
  • Botulinum type-A toxin is widely used for aesthetic and medical treatments, but type-B toxin is gaining interest for patients resistant to type-A.
  • The study reviewed FDA-approved uses of rimabotulinumtoxinB and off-label indications, highlighting its varying effectiveness depending on the condition treated.
  • Type B toxin is safe and effective for conditions like facial wrinkles, cervical dystonia, sialorrhea, and hyperhidrosis, although common side effects include dry mouth and dysphagia. It shows faster action and a dose-dependent effect profile.
View Article and Find Full Text PDF
Article Synopsis
  • - An 11-year-old boy experienced severe abdominal pain, sialorrhea, and food impaction for a week, with a history of similar symptoms treated as a pharyngeal phlegmon ten months prior.
  • - Diagnostic tests revealed mild inflammatory markers, a trachea deviation, and a tubular esophageal duplication identified via thoracic CT and endoscopy.
  • - The patient was admitted for hydration, pain relief, and antibiotics, showing improvement without complications, while esophageal duplications are rare congenital anomalies that can lead to various symptoms and may require surgical intervention.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!